Fátima Carneiro

Author PubWeight™ 79.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002 4.43
2 Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006 2.89
3 The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 2005 2.83
4 A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003 2.39
5 Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta 2012 1.64
6 Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006 1.55
7 Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 2006 1.43
8 Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003 1.42
9 BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 2008 1.30
10 Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006 1.29
11 Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr 2009 1.28
12 The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007 1.23
13 Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009 1.21
14 Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev 2007 1.21
15 E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 2004 1.17
16 Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch 2014 1.15
17 Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res 2009 1.14
18 Oncogenic mutations in gastric cancer with microsatellite instability. Eur J Cancer 2011 1.14
19 Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009 1.12
20 De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest 2010 1.10
21 The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 2009 1.09
22 Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiol Biomarkers Prev 2007 1.08
23 Epidermal growth factor receptor structural alterations in gastric cancer. BMC Cancer 2008 1.07
24 Diagnosis of gastric syphilis by direct immunofluorescence staining and real-time PCR testing. J Clin Microbiol 2006 1.06
25 Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest 2002 1.05
26 E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet 2003 1.02
27 E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta 2013 1.01
28 Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 2001 0.98
29 The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev 2008 0.98
30 Evaluation of clinico-pathological features and Helicobacter pylori infection in gastric inflammatory fibroid polyps. Virchows Arch 2014 0.98
31 E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012 0.98
32 Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 2004 0.97
33 Colorectal cancer and RASSF family--a special emphasis on RASSF1A. Int J Cancer 2012 0.96
34 Gastric cancer: adding glycosylation to the equation. Trends Mol Med 2013 0.96
35 MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer 2010 0.94
36 Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort. Cancer Causes Control 2010 0.93
37 Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis. Int J Surg Pathol 2003 0.93
38 Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family. Virchows Arch 2004 0.92
39 Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol Biomarkers Prev 2008 0.92
40 DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics 2007 0.91
41 Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch 2008 0.91
42 Genetic changes of CEBPA in cancer: mutations or polymorphisms? J Clin Oncol 2007 0.90
43 Helicobacter pylori colonization of the adenotonsillar tissue: fact or fiction? Int J Pediatr Otorhinolaryngol 2010 0.89
44 DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol 2008 0.88
45 NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis 2005 0.88
46 Antioxidant vitamins and risk of gastric cancer: a case-control study in Portugal. Nutr Cancer 2006 0.88
47 Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Exp Cell Res 2005 0.88
48 Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2010 0.88
49 E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 2013 0.87
50 Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4. Histochem Cell Biol 2009 0.87
51 Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol 2006 0.87
52 E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Hum Mol Genet 2011 0.87
53 C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab Invest 2010 0.87
54 Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol 2013 0.86
55 Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours. Hum Mol Genet 2009 0.86
56 Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas. J Pathol 2003 0.86
57 CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer 2008 0.85
58 Genetic screening for familial gastric cancer. Hered Cancer Clin Pract 2004 0.83
59 Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. BMC Cancer 2014 0.83
60 Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections. Virchows Arch 2011 0.82
61 First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies? Fam Cancer 2012 0.81
62 Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2. Histopathology 2014 0.80
63 Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection. J Infect 2006 0.80
64 Kidney histologic alterations in α-Galactosidase-deficient mice. Virchows Arch 2011 0.79
65 Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC). Eur J Hum Genet 2013 0.79
66 Who takes the lead in the development of ulcerative colitis-associated colorectal cancers: mutator, suppressor, or methylator pathway? Cancer Genet Cytogenet 2005 0.78
67 Association between environmental factors and CDX2 expression in gastric cancer patients. Eur J Cancer Prev 2012 0.77
68 First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch 2013 0.77
69 Cereal fiber intake may reduce risk of gastric adenocarcinomas: the EPIC-EURGAST study. Int J Cancer 2007 0.77
70 Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations. Int J Cancer 2014 0.77
71 PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori. BMC Microbiol 2011 0.77
72 AIRP best cases in radiologic-pathologic correlation: gastroblastoma: a rare biphasic gastric tumor. Radiographics 2014 0.77
73 History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family. Biomed Res Int 2012 0.76
74 Familial occurrence of nodular regenerative hyperplasia of the liver. Am J Gastroenterol 2013 0.75
75 GRIM-19 mutations are not associated with Crohn's disease. Inflamm Bowel Dis 2008 0.75
76 Metastatic cutaneous Crohn's disease of the face: a case report and review of the literature. Eur J Gastroenterol Hepatol 2011 0.75
77 Establishment of a Tumour Bank: the experience of the Department of Pathology of Hospital S. João (Porto, Portugal). Cell Tissue Bank 2008 0.75
78 Coexistence of Kaposi sarcoma and gastric diffuse large B-cell lymphoma in a HIV-infected patient. Rev Esp Enferm Dig 2015 0.75
79 Travelogue. Int J Surg Pathol 2010 0.75
80 Clear cell change in colonic polyps. Int J Surg Pathol 2008 0.75
81 Vascular invasion in thyroid and gastric carcinomas. Ultrastruct Pathol 2003 0.75
82 Sporadic, syndromic, and Zollinger-Ellison syndrome associated fundic gland polyps consistently express cytokeratin 7. Virchows Arch 2002 0.75
83 Adenocarcinoma of the cecum as the first manifestation of ulcerative colitis complicated by primary sclerosing cholangitis and endomyocardial fibrosis. Inflamm Bowel Dis 2002 0.75
84 Phlegmonous gastritis: a rare cause of abdominal pain. J Pediatr Gastroenterol Nutr 2015 0.75
85 Immunophenotype of sporadic and familial adenomatous polyposis associated fundic gland polyps: a mucin and MIB1 study. Pol J Pathol 2006 0.75
86 Ingestion of a natural mineral-rich water in an animal model of metabolic syndrome: effects in insulin signalling and endoplasmic reticulum stress. Horm Mol Biol Clin Investig 2016 0.75
87 Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence? Inflamm Bowel Dis 2017 0.75